[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"IDeA States Pediatric Clinical Trials Network\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":106},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,48,77],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":20,"enrollmentInfo":21,"targetDuration":4,"studyType":24,"phases":25,"briefSummary":27,"conditions":28,"keywords":31,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":47},"100573218","a-pilot-study-of-a-remote-adhd-monitoring-program-100573218",false,"NCT06743425","A Pilot Study of a Remote ADHD Monitoring Program","A Pilot Study of a Remote Attention-Deficit\u002FHyperactivity Disorder Monitoring Program (RAMP) for Children in Rural Areas","RAMP","Inclusion Criteria:\n\nThe child must\n\n* be under the care of a participating provider\n* be aged 5-11 at enrollment\n* have a diagnosis of ADHD\n* be initiating stimulant medication for treatment for the first time or have not received stimulant medication for the last 6 months\n* be attending in-person elementary school\n\nThe Primary caregiver must\n\n* be willing and legally able to give consent\n* have access to a smartphone\n* be English-speaking\n* reside with the child at least 3 days per week\n* complete an initial symptom assessment prior to starting stimulant treatment and be willing to provide a copy to the study team\n\nThe provider must\n\n* manage ADHD care in patients age 5-11 years\n* provide informed consent\n* agree to use the RAMP platform if they care for patients randomized to use it\n* agree to provide information to potential participants about the study and contact the research coordinator if interested\n\nExclusion Criteria:\n\nChild:\n\n* has serious mental health comorbidities (Children with depression, anxiety, oppositional defiant disorder will be permitted to participate. Children with schizophrenia, bipolar disorder, conduct disorder and those who have been hospitalized for any mental health condition will be excluded from the study.)\n* has severe neurodevelopment disorders (Children with well-controlled seizure disorders will be permitted to participate.)\n* is currently receiving, or previously received, atypical antipsychotic medication treatment\n* is or becomes pregnant",true,"ALL","5 Years","11 Years",{"count":22,"type":23},36,"ESTIMATED","INTERVENTIONAL",[26],"NA","RAMP is a pilot study examining the use of an Attention-Deficit\u002FHyperactivity Disorder (ADHD) Monitoring Program during the early stages of treating ADHD in children living in rural settings. This trial will enroll 36 caregiver\u002Finfant dyads across 2 sites and will evaluate feasibility endpoints rather than clinical outcomes. Enrolled participants will be randomized 1:1 to the intervention group (RAMP reports) or control group (digital education handouts). The study duration is 10 months, including start-up, enrollment and intervention, and data analysis and manuscript submission.",[29,30],"Attention-deficit\u002FHyperactivity Disorder","ADHD",[32,33,34],"Rural health","Vanderbilt","Text-based Symptom Reporting","RECRUITING","2026-04-27",{"date":38,"type":39},"2026-04-28","ACTUAL",{"date":41,"type":39},"2025-02-04",{"date":43,"type":23},"2026-07-01",{"name":45,"class":46},"IDeA States Pediatric Clinical Trials Network","NETWORK",2,{"id":49,"slug":50,"hasResults":11,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":17,"sex":18,"minAge":56,"maxAge":57,"enrollmentInfo":58,"targetDuration":4,"studyType":24,"phases":60,"briefSummary":61,"conditions":62,"keywords":4,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":47},"100552914","talk-with-me-baby-to-enhance-the-early-home-language-environment-100552914","NCT06479278","Talk With Me Baby to Enhance the Early Home Language Environment","Talk With Me Baby: Leveraging Well-Child Care to Enhance the Early Home Language Environment for Rural and Underserved Children","TWMB","Inclusion Criteria:\n\nFor this study, each child-caregiver dyad will consist of:\n\n1. A caregiver who will receive TWMB during routine WCC visits for their child at participating clinics, and\n2. The child of the above caregiver for whom the WCC visits are conducted.\n\nA potential caregiver participant must meet all the following inclusion criteria to enroll in the study:\n\n1. Be the age of majority, or older, as defined by the state of residency.\n2. Able to complete study measures in English.\n3. Have the legal authority to consent to participate for themselves and to consent on behalf of their child.\n\nTo proceed to the follow-up portion of the study the caregiver (dyad) must have a LENA baseline assessment score that is ≤ 75th percentile compared to a child's age-referenced normative data.\n\nA potential child participant must meet all the following inclusion criteria to be enrolled in the study:\n\n1. Receive WCC at a participating clinic from a participating provider.\n2. Be zero to nine months (+ 0-30 days) old at enrollment.\n3. Was born at full term (\\> 37 weeks gestation).\n4. Was born in a singleton birth (i.e., was the only child delivered during the birth).","0 Months","9 Months",{"count":59,"type":23},66,[26],"The goal of this clinical trial is to learn if the Talk With Me Baby (TWMB) program improves the home-language environment for at-risk families with children ages two to six months when primary care providers deliver the program during well-child checkups. The main question it aims to answer is:\n\nWill the TWMB program increase the time a caregiver talks to their infant?\n\nParticipants will:\n\n1. Come to at least four well-child checkups\n2. Receive the TWMB program from the provider during the checkups\n3. Record their conversations with their infant before they receive the program and after they receive the program four times.",[63,64,65,66,67,68],"Language Development","Speech","Infant Development","Infant Behavior","Language, Child","Language","2025-08-27",{"date":71,"type":39},"2025-08-29",{"date":73,"type":39},"2025-02-03",{"date":75,"type":23},"2026-08-31",{"name":45,"class":46},{"id":78,"slug":79,"hasResults":11,"nctId":80,"briefTitle":81,"officialTitle":82,"acronym":83,"eligibilityCriteria":84,"healthyVolunteers":17,"sex":18,"minAge":4,"maxAge":85,"enrollmentInfo":86,"targetDuration":4,"studyType":24,"phases":88,"briefSummary":89,"conditions":90,"keywords":92,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":99,"lastUpdatePostDateStruct":100,"startDateStruct":102,"completionDateStruct":104,"leadSponsor":105,"locationsCount":5},"100548643","improving-neurodevelopmental-outcomes-after-prenatal-cannabinoid-in-utero-exposure-100548643","NCT06423664","Improving Neurodevelopmental ouTcomes After Prenatal Cannabinoid in uTero Exposure","Pilot Feasibility Trial of Improving Neurodevelopmental ouTcomes After Prenatal Cannabinoid in uTero Exposure (INTACT)","INTACT","Inclusion Criteria:\n\nBirthing Parent\n\n* Age of majority, as defined by the state of residency\n* Cannabinoid use during pregnancy confirmed with self-report\n* Have the ability to speak, read, and understand English\n* Birthing parent who delivered at one of the hospitals where study team members have clinical privileges to access medical records\n* Has parental custody of the infant\n* Singleton pregnancy with live birth\n* Has an electronic device capable of watching videos and able to stream\u002Fdownload videos for viewing and permitting video conferencing\n* Has study access to the internet\n\nInfant\n\n* Term infants at birth (\\>37 weeks' gestation)\n* Biological child of the birthing parent\n\nExclusion Criteria:\n\nBirthing Parent\n\n* Other illicit drug use, excluding cannabinoids, during pregnancy (such as heroin or cocaine) per self-reported or toxicology results\n* Opiate use (prescribed or unprescribed) per self-report or toxicology results during this pregnancy\n* Prolonged hospitalization following delivery longer than 7 days\n\nInfant\n\n* Has major birth defect(s) including physical anomalies including limb malformations\u002Fabsence of limbs or chromosomal abnormalities\n* Diagnosed with neonatal encephalopathy, metabolic disorder, stroke, intracranial hemorrhage, or meningitis during birth hospitalization\n* Received any major surgical intervention during the birth hospitalization or required a prolonged birth hospitalization (prolonged hospitalization being any hospitalization longer than 7 days)","7 Days",{"count":87,"type":23},20,[26],"The INTACT trial is a multisite pilot feasibility study aimed at testing the effectiveness of the INTACT Intervention program in improving neurodevelopmental outcomes in infants prenatally exposed to cannabinoids. The trial will enroll 20 birthing parent\u002Finfant dyads across three sites and will evaluate feasibility endpoints rather than clinical outcomes. The study duration is 22 months, including study start-up, enrollment and intervention, and data analysis and manuscript preparation.",[91],"Developmental Delay",[93,94,95,96,97,98],"Behavioral health intervention","Prenatal substance exposure","Neurodevelopmental outcomes","Pediatric intervention","Developmental disorders","Pediatric health","2025-06-23",{"date":101,"type":39},"2025-06-24",{"date":103,"type":39},"2025-02-06",{"date":75,"type":23},{"name":45,"class":46},""]